Preface
Lysophospholipid signaling in cancer and immunity at a glance
Translational Cancer Research
2015;
4
(5)
:451-452
.
(22 October 2015)
Original Article
FOXC2 is overexpressed and participates in cell proliferation in ovarian cancer
Translational Cancer Research
2015;
4
(5)
:453-459
.
(22 October 2015)
Review Article
Sphingosine-1-phosphate (S1P) in cancer immunity and development
Translational Cancer Research
2015;
4
(5)
:460-468
.
(22 October 2015)
Sphingosine-1-phosphate in inflammatory bowel disease and colitis-associated colon cancer: the fat’s in the fire
Translational Cancer Research
2015;
4
(5)
:469-483
.
(22 October 2015)
Ceramide and sphingosine-1-phosphate in cancer, two faces of the sphinx
Translational Cancer Research
2015;
4
(5)
:484-499
.
(22 October 2015)
Angiogenic effect of lysophosphatidic acid receptors on cervical cancer cells
Translational Cancer Research
2015;
4
(5)
:500-526
.
(22 October 2015)
Lysophosphatidic acid in prostate cancer progression
Translational Cancer Research
2015;
4
(5)
:527-536
.
(22 October 2015)
Lysophosphatidic acid as a regulator of lymphocyte trafficking in the lymph nodes
Translational Cancer Research
2015;
4
(5)
:537-543
.
(22 October 2015)
Lysophospholipid receptor signaling in zebrafish development
Translational Cancer Research
2015;
4
(5)
:544-556
.
(22 October 2015)
Consensus
National consensus in China on diagnosis and treatment of patients with advanced breast cancer
Translational Cancer Research
2015;
4
(5)
:557-573
.
(22 October 2015)
Commentary
The factors affecting local tumor control after stereotactic body radiotherapy for non-small cell lung cancer
Translational Cancer Research
2015;
4
(5)
:574-577
.
(22 October 2015)
An in silico approach to treating “the right patient with the right drug at the right dose at the right time”
Translational Cancer Research
2015;
4
(5)
:578-579
.
(22 October 2015)
News
Translational Cancer Research is indexed in SCIE
Translational Cancer Research
2015;
4
(5)
:E16
.
(22 October 2015)
Disclosure:
The focused issue “Lysophospholipids on Immunity and Cancer” was commissioned by the editorial office, Translational Cancer Research without any sponsorship or funding. Hsinyu Lee and Markus H. Gräler served as the unpaid Guest Editors for the focused issue.
